Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tesamorelin alone reduces visceral fat by 15 to 20% without necessarily changing scale weight
According to the FDA submission for Wegovy approval (the weight loss medication produced by NovoNordisk that contains the active ingredient semaglutide), the average weight loss over 1 year and 4 months was 15.1%
There were 468 reports of GLP-1-related thyroid cancer cases to the Food and Drug Administration between 2006 and 2023, including 18 deaths
Results vary individually, but 89% of tirzepatide users and 69% of semaglutide users lose at least 10% of their body weight
Personalized Dosing Medication dosage and timing are customized to minimize discomfort and support long-term success
US$ 20.25
US$ 27.67
US$ 21.94
US$ 21.28
US$ 20.69
US$ 28.65
